1. 1) Simonneau G, Gatzoulis MA, Adatia I, et al: Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2013; 62 Suppl: D34–D41
2. 2) Abman SH, Hansmann G, Archer SL, et al: American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Surgery and Anesthesia; and the American Thoracic Society: Pediatric Pulmonary Hypertension: Guidelines from the American Heart Association and American Thoracic Society. Circulation 2015; 132: 2037–2099
3. 3) Hansmann G, Apitz C: Treatment of children with pulmonary hypertension: Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK. Heart 2016; 102 Suppl 2: ii67–ii85
4. 4) Douwes JM, van Loon RL, Hoendermis ES, et al: Acute pulmonary vasodilator response in paediatric and adult pulmonary arterial hypertension: Occurrence and prognostic value when comparing three response criteria. Eur Heart J 2011; 32: 3137–3146
5. 5) Douwes JM, Humpl T, Bonnet D, et al: TOPP Investigators: Acute Vasodilator Response in Pediatric Pulmonary Arterial Hypertension: Current clinical practice from the TOPP registry. J Am Coll Cardiol 2016; 67: 1312–1323